This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

TAVR vs. Surgery Among Children and Young Adults with Congenital Heart Disease

Thursday, June 16, 2022

Submitted by



Michael Walter

New findings published in the American Journal of Cardiology posit that transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) are associated with similar short-term outcomes among pediatric patients presenting with congenital heart disease (CHD). However, SAVR patients in the study had “significantly” longer ICU stays and hospitalization times and were more likely to require medications to control their blood pressure following the procedure.


That is great to know that the procedure works for youngsters. Hopefully the intermediate and long term results to be also good to avoid future possible valve in valve scenario or difficult redo operation.

Add comment

Log in or register to post comments